AKT1 and neoplasm: This signaling route, similarly to the IL-10-enhancing effect of the PI3K/Akt/mTOR pathway in monocytes/macrophages [124], is used by tumor cells to promote immune tolerance and maintain M2 phenotype in TAMs [6].